Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aziz Zaanan

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
Drugs|July 27, 2019
The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal CancerJulien Taieb, Andreas Jung, Andrea Sartore-Bianchi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 5, 2023
Addition of trastuzumab to perioperative chemotherapy in HER2-positive gastroesophageal adenocarcinoma patients: A multicenter retrospective observational AGEO studyAnne-Esther Frydman, Antoine Drouillard, Emilie Soularue, et al.
British Journal of Cancer|June 30, 2020
A comprehensive population-based study comparing the phenotype and genotype in a pretherapeutic screen of dihydropyrimidine dehydrogenase deficiencyNicolas Pallet, Salma Hamdane, Simon Garinet, et al.
Hepato-Gastroenterology|August 13, 2013
Biomarkers and prognosis after R0 resection of colorectal liver metastasesFrançois Radais, Aziz Zaanan, Jérémie H Lefévre, et al.
Cancer|March 23, 2011
Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO studyAziz Zaanan, Mélanie Gauthier, David Malka, et al.
Cancer Treatment Reviews|June 3, 2020
Plasma circulating tumor DNA in pancreatic adenocarcinoma for screening, diagnosis, prognosis, treatment and follow-up: A systematic reviewRaëf Abdallah, Valérie Taly, Shulin Zhao, et al.
Therapeutic Advances in Gastroenterology|June 7, 2018
Impact of an optimized colonoscopic screening program for patients with Lynch syndrome: 6-year results of a specialized French networkGuillaume Perrod, Elia Samaha, Gabriel Rahmi, et al.
Statistical Methods in Medical Research|April 10, 2019
Integration of elicited expert information via a power prior in Bayesian variable selection: Application to colon cancer dataSandrine Boulet, Moreno Ursino, Peter Thall, et al.
Bulletin Du Cancer|March 7, 2015
Efficacy and safety of trastuzumab in combination with oxaliplatin and fluorouracil-based chemotherapy for patients with HER2-positive metastatic gastric and gastro-oesophageal junction adenocarcinoma patients: a retrospective studyÉmilie Soularue, Romain Cohen, Christophe Tournigand, et al.
Clinics and Research in Hepatology and Gastroenterology|November 13, 2012
Chemosensitivity in ovarian metastases from gastric cancer: a case seriesBertrand Brieau, Hélène Roussel, Theofano Markoutsaki, et al.
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
Drugs|July 27, 2019
The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal CancerJulien Taieb, Andreas Jung, Andrea Sartore-Bianchi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 5, 2023
Addition of trastuzumab to perioperative chemotherapy in HER2-positive gastroesophageal adenocarcinoma patients: A multicenter retrospective observational AGEO studyAnne-Esther Frydman, Antoine Drouillard, Emilie Soularue, et al.
British Journal of Cancer|June 30, 2020
A comprehensive population-based study comparing the phenotype and genotype in a pretherapeutic screen of dihydropyrimidine dehydrogenase deficiencyNicolas Pallet, Salma Hamdane, Simon Garinet, et al.
Hepato-Gastroenterology|August 13, 2013
Biomarkers and prognosis after R0 resection of colorectal liver metastasesFrançois Radais, Aziz Zaanan, Jérémie H Lefévre, et al.
Cancer|March 23, 2011
Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO studyAziz Zaanan, Mélanie Gauthier, David Malka, et al.
Cancer Treatment Reviews|June 3, 2020
Plasma circulating tumor DNA in pancreatic adenocarcinoma for screening, diagnosis, prognosis, treatment and follow-up: A systematic reviewRaëf Abdallah, Valérie Taly, Shulin Zhao, et al.
Therapeutic Advances in Gastroenterology|June 7, 2018
Impact of an optimized colonoscopic screening program for patients with Lynch syndrome: 6-year results of a specialized French networkGuillaume Perrod, Elia Samaha, Gabriel Rahmi, et al.
Statistical Methods in Medical Research|April 10, 2019
Integration of elicited expert information via a power prior in Bayesian variable selection: Application to colon cancer dataSandrine Boulet, Moreno Ursino, Peter Thall, et al.
Bulletin Du Cancer|March 7, 2015
Efficacy and safety of trastuzumab in combination with oxaliplatin and fluorouracil-based chemotherapy for patients with HER2-positive metastatic gastric and gastro-oesophageal junction adenocarcinoma patients: a retrospective studyÉmilie Soularue, Romain Cohen, Christophe Tournigand, et al.
Clinics and Research in Hepatology and Gastroenterology|November 13, 2012
Chemosensitivity in ovarian metastases from gastric cancer: a case seriesBertrand Brieau, Hélène Roussel, Theofano Markoutsaki, et al.
Pageof 14